RxDoctor Payments Data

David Boardman, DO

Family Medicine · Bedford, INNPI 1750382040

Payments from drug & device makers

$204in general payments, 2019–2025

Across 10 payments — averaging $20.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$58
  • E.r. Squibb & Sons, L.L.C.$46
  • Abiomed$29
  • Edwards Lifesciences$28
  • Boston Scientific$15
  • Exact Sciences$15
  • plus $13 from 1 others

What the payments were for

  • Food & beverage$15877%
  • Education$4623%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$204 in reported general payments places this provider in the 30th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$203,251
Medicare patients
484
Services billed
2,630

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban191$190,092
TrulicityDulaglutide81$107,377
OzempicSemaglutide88$104,922
JardianceEmpagliflozin110$96,841
MounjaroTirzepatide60$73,879
JanuviaSitagliptin Phosphate58$59,006
Dupixent SyringeDupilumab12$43,919
Janumet XrSitagliptin Phos/Metformin Hcl48$37,879
LinzessLinaclotide52$37,711
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog93$36,775
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$34,319
Lantus SolostarInsulin Glargine,hum.Rec.Anlog179$32,989
XareltoRivaroxaban24$29,612
Breo ElliptaFluticasone/Vilanterol56$29,433
FarxigaDapagliflozin Propanediol25$28,104

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$58$37,71152 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Bedford

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →